Precisioneffect went into 2018 with the usual slate of outward-facing goals but a relatively uncommon inward-facing one: to find out just what its employees truly thought about the company’s culture.

After conducting a host of research and listening to staff concerns, the agency determined that one of its culture’s key assets was a team-first mindset. Thus was born “Wecentricity,” an internal campaign designed to encourage employees to be their authentic selves at work, share their ideas (and be receptive to others’) and work together more effectively. Staffers from Precisioneffect’s three offices — in Boston; Costa Mesa, California; and London — came together for the formal unveiling March 1, 2019.

“‘Wecentricity’ is a way to highlight our culture so that employees can celebrate it and articulate it for new employees,” explains Precisioneffect president Carolyn Morgan, who adds that the campaign’s debut was well timed. “This year was an inflection point in terms of the quality of opportunities we were able to participate in and the quality of staff we were able to bring on.”

The agency grew by 30 people in 2018, to 175 from 145 at the end of 2017. Key hires included EVP, managing director Laurence Richards (who arrived from Juice Pharma); SVP, client service Adrienne Morgan (from H4B Chelsea); senior director, media and engagement Jeff Porzio (from PJA Advertising + Marketing); and director, project management and operations Kim Viges (from her own consultancy).

Revenue increased by nearly 17%, to $34.6 million from $29.6 million in 2017. The growth came on the back of five new assignments, including work from Pfizer, Lexicon Pharmaceuticals, Blueprint Medicines, Alnylam Pharmaceuticals and Amicus Therapeutics.

Even as a veteran of the healthcare and pharma worlds, Morgan finds herself impressed by the industry’s recent scientific breakthroughs. “To think about the changes Blueprint is going to be [fostering] in oncology or Alnylam in rare disease or Amicus in moving patients from ERT therapy to oral therapy — it’s unbelievable to be a part of the story,” she says.

To maintain its appeal to such clients, Precisioneffect has broadened its offerings. During 2018, the agency grew its media-engagement team and bolstered its AI capabilities. “We’re starting to see AI take off,” Morgan explains. “Our clients are interested in giving physicians and patients information along their journey that encourages them to take the call to action and move to the next step.”

And for those projects Precisioneffect doesn’t feel fully equipped to handle on its own — ones in the pricing/value arena, for example — the company can tap the deep experience of its Precision Value & Health siblings. “Clients are asking for us to bring that expertise to the table, so we are lucky that Precision is ahead of the game,” Morgan says. “We want to make sure we’re keeping an eye on pricing and competition in order to help our clients think it through. In rare disease, oncology and across all the therapeutic categories we work in, competition is fierce, so this is key.”